<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Conteduca G</submitter><funding>Italian Ministry of Health</funding><funding>AssiiGulliver Association</funding><funding>AssiGulliver Italian Association</funding><funding>Fondazione Sardegna</funding><pagination>988</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9324496</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(7)</volume><pubmed_abstract>An increasing amount of evidence indicates the critical role of the NSD1 gene in Sotos syndrome (SoS), a rare genetic disease, and in tumors. Molecular mechanisms affected by NSD1 mutations are largely uncharacterized. In order to assess the impact of NSD1 haploinsufficiency in the pathogenesis of SoS, we analyzed the gene expression profile of fibroblasts isolated from the skin samples of 15 SoS patients and of 5 healthy parents. We identified seven differentially expressed genes and five differentially expressed noncoding RNAs. The most upregulated mRNA was stratifin (SFN) (fold change, 3.9, Benjamini−Hochberg corrected p &lt; 0.05), and the most downregulated mRNA was goosecoid homeobox (GSC) (fold change, 3.9, Benjamini−Hochberg corrected p &lt; 0.05). The most upregulated lncRNA was lnc-C2o</pubmed_abstract><journal>Life (Basel, Switzerland)</journal><pubmed_title>&lt;i>NSD1&lt;/i> Mutations in Sotos Syndrome Induce Differential Expression of Long Noncoding RNAs, miR646 and Genes Controlling the G2/M Checkpoint.</pubmed_title><pmcid>PMC9324496</pmcid><funding_grant_id>AssiiGulliver 2019</funding_grant_id><funding_grant_id>Fondazione Sardegna</funding_grant_id><funding_grant_id>Ricerca Corrente 2020</funding_grant_id><funding_grant_id>Ricerca Corrente 2021</funding_grant_id><pubmed_authors>Pinto R</pubmed_authors><pubmed_authors>Coco S</pubmed_authors><pubmed_authors>Conteduca G</pubmed_authors><pubmed_authors>Malacarne M</pubmed_authors><pubmed_authors>Cangelosi D</pubmed_authors><pubmed_authors>Baldo C</pubmed_authors><pubmed_authors>Coviello DA</pubmed_authors><pubmed_authors>Testa B</pubmed_authors><pubmed_authors>Arado A</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>NSD1&lt;/i> Mutations in Sotos Syndrome Induce Differential Expression of Long Noncoding RNAs, miR646 and Genes Controlling the G2/M Checkpoint.</name><description>An increasing amount of evidence indicates the critical role of the NSD1 gene in Sotos syndrome (SoS), a rare genetic disease, and in tumors. Molecular mechanisms affected by NSD1 mutations are largely uncharacterized. In order to assess the impact of NSD1 haploinsufficiency in the pathogenesis of SoS, we analyzed the gene expression profile of fibroblasts isolated from the skin samples of 15 SoS patients and of 5 healthy parents. We identified seven differentially expressed genes and five differentially expressed noncoding RNAs. The most upregulated mRNA was stratifin (SFN) (fold change, 3.9, Benjamini−Hochberg corrected p &lt; 0.05), and the most downregulated mRNA was goosecoid homeobox (GSC) (fold change, 3.9, Benjamini−Hochberg corrected p &lt; 0.05). The most upregulated lncRNA was lnc-C2o</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2026-04-08T11:45:41.234Z</modification><creation>2022-08-07T22:00:48.743Z</creation></dates><accession>S-EPMC9324496</accession><cross_references><pubmed>35888078</pubmed><doi>10.3390/life12070988</doi></cross_references></HashMap>